Similar articles

• Medical Expenditures Among Medicare Beneficiaries with Statin-Associated Adverse Effects Following Myocardial Infarction.

  Colantonio LD, Deng L, Chen L, Farkouh ME, Monda KL, Harrison DJ, Maya JF, Kilgore ML, Muntner P, Rosenson RS. Colantonio LD, et al. Cardiovasc Drugs Ther. 2018 Dec;32(6):601-610. doi: 10.1007/s10557-018-6840-8. Cardiovasc Drugs Ther. 2018. PMID: 30446883
• Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project.

  Marciniak TA, Ellerbeck EF, Radford MJ, Kresowik TF, Gold JA, Krumholz HM, Kiefe CI, Allman RM, Vogel RA, Jencks SF. Marciniak TA, et al. JAMA. 1998 May 6;279(17):1351-7. doi: 10.1001/jama.279.17.1351. JAMA. 1998. PMID: 9582042
• Process and outcome of care for acute myocardial infarction among Medicare beneficiaries in Connecticut: a quality improvement demonstration project.

  Meehan TP, Hennen J, Radford MJ, Petrillo MK, Elstein P, Ballard DJ. Meehan TP, et al. Ann Intern Med. 1995 Jun 15;122(12):928-36. doi: 10.7326/0003-4819-122-12-199506150-00007. Ann Intern Med. 1995. PMID: 7755229
• Payments for acute myocardial infarction episodes-of-care initiated at hospitals with and without interventional capabilities.

  Ben-Josef G, Ott LS, Spivack SB, Wang C, Ross JS, Shah SJ, Curtis JP, Kim N, Krumholz HM, Bernheim SM. Ben-Josef G, et al. Circ Cardiovasc Qual Outcomes. 2014 Nov;7(6):882-8. doi: 10.1161/CIRCOUTCOMES.114.000927. Epub 2014 Nov 11. Circ Cardiovasc Qual Outcomes. 2014. PMID: 25387777
• Specialty of principal care physician and Medicare expenditures in patients with coronary artery disease: impact of comorbidity and severity.

  McNamara RL, Powe NR, Thiemann DR, Shaffer T, Weller W, Anderson G. McNamara RL, et al. Am J Manag Care. 2001 Mar;7(3):261-6. Am J Manag Care. 2001. PMID: 11258143